DK0560348T3 - Thieno-(3,2-b)pyridinderivater til behandling af gastrointestinale sygdomme - Google Patents

Thieno-(3,2-b)pyridinderivater til behandling af gastrointestinale sygdomme

Info

Publication number
DK0560348T3
DK0560348T3 DK93103899T DK93103899T DK0560348T3 DK 0560348 T3 DK0560348 T3 DK 0560348T3 DK 93103899 T DK93103899 T DK 93103899T DK 93103899 T DK93103899 T DK 93103899T DK 0560348 T3 DK0560348 T3 DK 0560348T3
Authority
DK
Denmark
Prior art keywords
gastric
present
thieno
compound
treatment
Prior art date
Application number
DK93103899T
Other languages
Danish (da)
English (en)
Inventor
Akihiro Tobe
Satoshi Yamazaki
Akira Maruyama
Shigeru Ogawa
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of DK0560348T3 publication Critical patent/DK0560348T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93103899T 1992-03-12 1993-03-10 Thieno-(3,2-b)pyridinderivater til behandling af gastrointestinale sygdomme DK0560348T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5386492 1992-03-12

Publications (1)

Publication Number Publication Date
DK0560348T3 true DK0560348T3 (da) 2002-11-04

Family

ID=12954639

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93103899T DK0560348T3 (da) 1992-03-12 1993-03-10 Thieno-(3,2-b)pyridinderivater til behandling af gastrointestinale sygdomme

Country Status (11)

Country Link
US (1) US5352685A (de)
EP (1) EP0560348B1 (de)
JP (1) JP2699794B2 (de)
KR (1) KR100263414B1 (de)
AT (1) ATE220403T1 (de)
CA (1) CA2091506C (de)
DE (1) DE69332095T2 (de)
DK (1) DK0560348T3 (de)
ES (1) ES2179826T3 (de)
PT (1) PT560348E (de)
TW (1) TW229211B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227747A1 (de) * 1992-08-21 1994-02-24 Basf Ag Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
AU782648B2 (en) * 1999-11-23 2005-08-18 Janssen Pharmaceutica N.V. Use of 5HT3 agonists for relaxing the fundus
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
AR036041A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
AR036040A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
DE60231017D1 (de) * 2001-08-24 2009-03-12 Mitsubishi Tanabe Pharma Corp Mittel zur Prävention und Behandlung des vorwiegend durch Obstipation geprägten Reizdarms
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
CA2460075A1 (en) * 2001-09-12 2003-03-20 Donn Gregory Wishka Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases
KR100614900B1 (ko) 2001-10-02 2006-08-25 파마시아 앤드 업존 캄파니 엘엘씨 질병의 치료를 위한 아자비시클릭-치환된 융합-헤테로아릴화합물
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
DE10164139A1 (de) * 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
AR038118A1 (es) 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
AR038294A1 (es) * 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
AR038117A1 (es) 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
EP1476448A2 (de) * 2002-02-19 2004-11-17 PHARMACIA & UPJOHN COMPANY Azabicyclische verbindungen zur behandlung von erkrankungen
CA2476681A1 (en) * 2002-02-19 2003-08-28 Bruce N. Rogers Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
CA2503786A1 (en) * 2002-11-01 2004-05-13 Pharmacia & Upjohn Company Llc Compounds having both alpha7 nicotinic agonist activity and 5ht, antagonist activity for treatment of cns diseases
EP1567163B1 (de) * 2003-01-13 2007-04-11 Dynogen Pharmaceuticals Inc. Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
NZ541008A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders
JP2006522144A (ja) * 2003-04-04 2006-09-28 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 下部尿路障害の治療方法
EP1663313A2 (de) * 2003-08-29 2006-06-07 Dynogen Pharmaceuticals Inc. Zusammensetzungen zur behandlung von gastrointestinalen motilitätsstörungen
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
EP2170901B1 (de) * 2007-05-25 2015-07-01 Vertex Pharmaceuticals Incorporated Modulatoren des cystic fibrosis transmembrane conductance regulator
CN101868236A (zh) * 2007-06-07 2010-10-20 埃杜萨药品公司 用于治疗胃食管返流性疾病的组合物
KR20120104512A (ko) 2009-07-14 2012-09-21 알바니 몰레큘라 리써치, 인크. 5-ｈｔ3 수용체 조절체, 이의 제조 방법, 및 그의 용도
BR112020011889A2 (pt) * 2017-12-13 2020-11-24 Glaxosmithkline Intellectual Property Development Limited piridinas fundidas que agem como inibidores de h-pgds

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56226B1 (en) * 1982-04-14 1991-05-22 Beecham Group Plc Substituted azabicyclo compounds,process for their preparation and pharmaceutical compositions containing them
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
CH664567A5 (de) * 1983-08-26 1988-03-15 Sandoz Ag Aromatische carbonsaeure- und sulfonsaeureester oder -amide.
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
DE201165T1 (de) * 1985-03-14 1989-04-20 Beecham Group P.L.C., Brentford, Gb Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome".
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
EP0254584B1 (de) * 1986-07-25 1992-10-07 Beecham Group Plc Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
WO1988003801A1 (en) * 1986-11-21 1988-06-02 Glaxo Group Limited Medicaments for treatment or prevention of withdrawal syndrome
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
IL87674A (en) * 1987-09-08 1993-08-18 Lilly Co Eli Azabicycloalkyl esters and amides of heterocyclic acids, their preparation and pharmaceutical compositions containing them
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
JP2643274B2 (ja) * 1988-04-08 1997-08-20 三菱化学株式会社 イミダゾ〔１，２−ａ〕ピリジン誘導体
US4933445A (en) * 1988-11-29 1990-06-12 Rorer Pharmaceutical Corporation Heteroazabenzobicyclic carboxamide 5-HT3 antagonists
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
CA2020315A1 (en) * 1989-07-03 1991-01-04 Takeshi Kawakita Benzazine compounds and pharmaceutical uses thereof
GB2236751B (en) * 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
JPH03275684A (ja) * 1990-03-26 1991-12-06 Yoshitomi Pharmaceut Ind Ltd ベンゾチアジン化合物
JP3122671B2 (ja) * 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
JPH04103583A (ja) * 1990-08-24 1992-04-06 Hokuriku Seiyaku Co Ltd アミド化合物
US5200415A (en) * 1990-11-01 1993-04-06 Asahi Kasei Kogyo Kabushiki Kaisha Pyrazolo[1,5-a]pyridine-3-carboxylic acid derivatives and their pharmaceutical use
GB9103839D0 (en) * 1991-02-23 1991-04-10 Smithkline Beecham Plc Pharmaceuticals
US5155115A (en) * 1991-03-12 1992-10-13 Kyowa Hakko Kogyo Co., Ltd. Thienopyridine derivatives
IT1250629B (it) * 1991-07-04 1995-04-21 Boehringer Ingelheim Italia Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.

Also Published As

Publication number Publication date
US5352685A (en) 1994-10-04
CA2091506A1 (en) 1993-09-13
DE69332095D1 (de) 2002-08-14
KR100263414B1 (ko) 2001-04-02
TW229211B (de) 1994-09-01
KR930019680A (ko) 1993-10-18
EP0560348A1 (de) 1993-09-15
ES2179826T3 (es) 2003-02-01
JPH05310747A (ja) 1993-11-22
ATE220403T1 (de) 2002-07-15
CA2091506C (en) 2001-05-29
EP0560348B1 (de) 2002-07-10
PT560348E (pt) 2002-11-29
JP2699794B2 (ja) 1998-01-19
DE69332095T2 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
DK0560348T3 (da) Thieno-(3,2-b)pyridinderivater til behandling af gastrointestinale sygdomme
KR920703627A (ko) 궤양 치료방법 및 조성물
WO2000076984A8 (en) Novel compounds, their use and preparation
WO2004085382A1 (ja) 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
DK0600725T3 (da) Farmaceutiske præparater indeholdende en guanidinothiazolforbindelse og antacider
MX9306333A (es) Composicion de ranitidina en forma de tableta masticable.
WO2005107719A3 (en) Pharmaceutical composition comprising hydrophobic drug having improved solubility
DE3874917T2 (de) Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE69739415D1 (de) Carbonsaeuren und ihre derivate und pharmazeutische zusammensetzungen die diese enthalten
ES2178169T3 (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
CA2219605A1 (en) Method of stimulating gastrointestinal motility with ellagic acid
DE69131907D1 (de) Thienodiazepinverbindungen und ihre verwendung
MY129173A (en) Novel cyclopentene derivatives useful as antagonists of the motilin receptor
IL97952A0 (en) Azatetracyclic compounds,their preparation and pharmaceutical compositions containing them
IE820222L (en) Tricyclic pyrroles
HUT71112A (en) Pharmaceutical composition for prophylaxis and treatment of myopia containing benzopyrano pyridin derivatives
GR3005563T3 (de)
JPS5764655A (en) Novel benzoylaminophenylcarboxylic acid derivative, its preparation, and drug composition comprising it
JPS56154478A (en) Spiro compound and its preparation
DE3663947D1 (en) New indole derivatives, the production and uses thereof
RU2033644C1 (ru) Способ профилактики эрозивно-язвенных поражений слизистой желудка у лабораторных животных
CA2219603A1 (en) Method of stimulating gastrointestinal motility with ellagic acid
TH48406A (de)
RU94014604A (ru) Способ арефлюксной резекции желудка
RU95103544A (ru) Способ хирургического лечения язвенной болезни двенадцатиперстной кишки, сочетающейся с рефлюкс-эзофагитом